PharmSci conference adds new research tracks 16/10/2026 • 18 hours ago AAPS launches new research tracks at PharmSci 360, exploring scientific research integrity in AI era and emerging drug development technologies.
AbbVie Reports High Cure Rate for Acute Hepatitis C 11/10/2026 • 6 days ago AbbVie's Maviret achieved a 96% cure rate in a Phase 3 trial for acute hepatitis C, leading to U.S. approval...
AI agents help manage data surge in trials 10/10/2026 • 7 days ago Phase-3 clinical trials are generating unprecedented data volumes, a trend that fuels the vision of an autonomous clinical trial while...
New Drug Survodutide Shows Promise for Obesity, Diabetes 05/10/2026 • 2 weeks ago Survodutide shows promise as a treatment for obesity and diabetes, with significant weight loss and improved glycaemic control in trials.
Moving to Wealthier Areas Cuts Diabetes Risk 03/10/2026 • 2 weeks ago Research presented at the European Association for the Study of Diabetes meeting in Milan indicates that moving from a high-poverty...
AI detects type 2 diabetes from short speech samples 01/10/2026 • 2 weeks ago Scientists report AI can detect type 2 diabetes from short speech samples at the European Association for the Study of...
ENT Surgeon Charges Fees Based on Patient Income 26/09/2026 • 3 weeks ago Dr Nandlal Manseta charges patients based on monthly income, with no fees for those without income. Consultations range from Rs...
Team Wins Innovator Award for Rural Surgery 11/09/2026 • 1 month ago Cuyuna Regional Medical Center won the 2026 Innovator Award by slashing rural surgery cancellations to just 2 percent.
EuBiologics Invests $10M, Raises US Vaccine JV Stake 31/08/2026 • 2 months ago EuBiologics investment of $10M secures majority stake in US vaccine JV. Explore the strategic move to control 80% of EuPOP...